Florent Carsuzaa

Dr. Florent Carsuzaa

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2020 in American Journal of Rhinology & Allergy
Verified
Journal Article
Open access
PDF file
ECEléonore Chary
Eléonore Chary
FCFlorent Carsuzaa
Florent Carsuzaa
JTJean-Paul Trijolet
Jean-Paul Trijolet
ACAnne-Laure Capitaine
Anne-Laure Capitaine
MRMariam Roncato-Saberan
Mariam Roncato-Saberan
XDXavier Dufour
Xavier Dufour
Background: Covid-19 is defined by an association of multiple symptoms, including frequently reported olfactory and gustatory disorders. Objective: The main purpose of this study was to analyze the prevalence of these neurosensory impairments in patients with Covid-19, and to assess short-term recovery. Methods: We performed a multicenter case series study during the Covid-19 epidemic. All patients presenting a RT-PCR-confirmed SARS-CoV-2 infection were included, whether hospitalized or treated at home. To analyze the prevalence and features of olfactory and gustatory dysfunctions, a phone interview was conducted 5 days after the positive PCR result. The questionnaire was submitted again 10 days later to patients having reported olfactory and gustatory disorders, in order to assess their recovery. Results: 115 patients were included in our study. 81 patients (70%) reported olfactory and gustatory disorders without nasal obstruction or rhinorrhea. These impairments were more frequently reported in the female population, young people, and house-bound patients with mild symptomatic forms. Short-term recovery assessed at Day 15 was complete for 64% of the patients, and incomplete in 33%. Median recovery time was 15 days (4–27 days) after olfactory or gustatory symptom onset. Conclusion: Olfactory and gustatory dysfunctions related to Covid-19 are frequently reported and prevalent in mild symptomatic forms of the disease. Recovery in most cases seems rapid and complete.

Verified
Journal Article
Open access
PDF file
FCFlorent Carsuzaa
Florent Carsuzaa
EBEMILIE BEQUIGNON
EMILIE BEQUIGNON
XDXavier Dufour
Xavier Dufour
GBGuillaume de Bonnecaze
Guillaume de Bonnecaze
JLJean-Claude Lecron
Jean-Claude Lecron
LLLaure Favot Laforge
Laure Favot Laforge
Cytokines are well known to play a central role in chronic rhinosinusitis with nasal polyps (CRSwNP), particularly in maintenance of the inflammatory response and the recruitment of eosinophils. The pathophysiological concepts concerning the involvement of inflammatory cytokines in CRSwNP have gradually evolved. Although the Th2 cytokines environment associated with an eosinophilic infiltration has retained a central role in the genesis of polyps, the role of other cytokine subpopulations has also and more recently been detailed, leading to a specific and complex signature in CRSwNP. The purpose of this review is to summarize the current state of knowledge about the cytokine signature in CRSwNP, the role of cytokines in the pathogenesis of this disease and in the intercellular dialog between epithelial cells, fibroblasts and inflammatory cells. Knowledge of this precise cytokine signature in CRSwNP is fundamental in the perspective of potential targeting biotherapies.

1 July 2021 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
FCFlorent Carsuzaa
Florent Carsuzaa
MLMichel Lapeyre
Michel Lapeyre
VGVincent Gregoire
Vincent Gregoire
PMPhilippe Maingon
Philippe Maingon
ABArnaud BEDDOK
Arnaud BEDDOK
Juliette THARIATJuliette THARIAT
Juliette THARIAT

Verified
Journal Article
Open access
PDF file
FCFlorent Carsuzaa
Florent Carsuzaa
ÉBÉmilie Béquignon
Émilie Béquignon
MBMatthieu Bainaud
Matthieu Bainaud
JJJean-François Jégou
Jean-François Jégou
XDXavier Dufour
Xavier Dufour
LLLaure Favot Laforge
Laure Favot Laforge
Chronic rhinosinusitis with nasal polyps (CRSwNP) is associated with inflammation and tissue remodeling including myofibroblasts differentiation and extracellular matrix (ECM) deposition mediated by TGF-β1 and IL-4. Oncostatin M (OSM) is a cytokine involved in fibrotic processes in other cellular subtypes. We investigated the mechanisms of action of OSM in the fibrosis process associated with CRSwNP. The expression of IL-4, OSM and TGF-β1 was assessed by RT-qPCR. Primary human cultures of nasal-polyp-derived fibroblasts were established and stimulated by TGF-β1 and/or IL-4 and/or OSM. The expression of ECM components and αSMA was determined by RT-qPCR and Western blot. TGF-β1-Smad3 signaling was investigated by immunofluorescence. TGF-β1, IL-4 and OSM as well as αSMA were overexpressed in nasal polyps when compared to noninflammatory nasal mucosa. In TGF-β1-stimulated nasal-polyp-derived fibroblasts, ECM genes and αSMA gene and protein were overexpressed, as well as αSMA in IL-4-stimulated fibroblasts. OSM counteracted the profibrotic effect of TGF-β1 on ECM components and αSMA. TGF-β1-induced nuclear translocation of Smad3 was completely reversed by OSM. OSM counteracts the profibrotic effect of IL-4 and also TGF-β1, by inhibiting the nuclear translocation of Smad3. We suggest OSM could be an efficient tool to protect against fibrosis in CRSwNP.

25 September 2021 in Cancers
Verified
Journal Article
Open access
PDF file
Juliette THARIATJuliette THARIAT
Juliette THARIAT
FCFlorent Carsuzaa
Florent Carsuzaa
PMPierre Yves Marcy
Pierre Yves Marcy
BVBenjamin VERILLAUD
Benjamin VERILLAUD
LGLudovic de Gabory
Ludovic de Gabory
FFFrancois Regis Ferrand
Francois Regis Ferrand
Radiotherapy plays an important role in the treatment of sinonasal cancer, mainly in the adjuvant setting after surgical resection. Many technological approaches have been described, including intensity-modulated radiotherapy, concomitant chemoradiotherapy, charged particle therapy or combined approaches. The choice is based on general criteria related to the oncological results and morbidity of each technique and their availability, as well as specific criteria related to the tumor (tumor extensions, pathology and quality of margins). The aims of this review are: (i) to provide an overview of the radiotherapy techniques available for the management of sinonasal malignant tumors and (ii) to describe the constraints and opportunities of radiotherapy owing to the recent developments of endonasal endoscopic surgery. The indication and morbidity of the different techniques will be discussed based on a critical literature review.

11 March 2024 in International Forum of Allergy & Rhinology
Verified
Journal Article
Open access
MFMaxime Fieux
Maxime Fieux
FCFlorent Carsuzaa
Florent Carsuzaa
YBYvan Bellanger
Yvan Bellanger
SBSophie Bartier
Sophie Bartier
VFVirginie Fournier
Virginie Fournier
EBEmilie Bequignon
Emilie Bequignon
Background: Chronic rhinosinusitis with nasal polyp (CRSwNP) is a typical type 2 inflammation involving interleukin (IL)‐4 and IL‐13. Dupilumab is a fully human monoclonal antibody targeting IL‐4 receptor α subunit, thereby blocking signaling by both cytokines. Our hypothesis was that IL‐4 and IL‐13, by inducing a severe epithelial dysregulation, are involved in CRSwNP pathogenesis. This study aimed to evaluate the in vitro direct effect of IL‐4, IL‐13, and dupilumab on nasal epithelial functions.Methods: Nasal polyps and control mucosa from 28 patients, as well as human nasal epithelial cells (HNEC) from 35 patients with CRSwNP were used. Three major epithelial functions were investigated: the epithelial barrier function (characterized by transepithelial electrical resistance measurements and tight junction protein expression), the ciliary motion (characterized by the ciliary beating efficiency index), and wound healing (characterized by the wound repair rate) under various stimulations (IL‐4, IL‐13, and dupilumab). The main outcome was a significant change in epithelial functions following exposure to IL‐4, IL‐13, and dupilumab for 48 h in the basal media.Results: IL‐4 (1, 10, and 100 ng/mL) but not IL‐13 induced a significant decrease in occludin and zonula‐occludens protein expression, ciliary beating efficiency, and wound repair rate in HNEC. Dupilumab (0.04 mg/mL) had no effect on HNEC and specifically restored all epithelial functions altered when cells were exposed to a 48‐h IL‐4 stimulation.Conclusion: Dupilumab, in vitro, restored epithelial integrity by counteracting the effect of IL‐4 on the epithelial barrier (increased epithelial permeability, decreased ciliary beating efficiency, and decreased wound repair rate).